bcbs glp-1 medications are getting a lot of attention but understanding how they work and the role nutrition plays matters! #OAND #eatrightohio Excellus clarifies GLP-1 coverage ahead

Stopping treatment with weight loss medications is associated with gradual weight gain and a loss of earlier improvements in heart and metabolic health, according to new research published by The BMJ

Retatrutide is the agonist of GLP-1 receptor, GIP receptor, and glucagon (GCG) receptor, which can reduce body weight and improve blood glucose by subcutaneous injection once a week(Rosenstock et al 2023)

But right now, even small improvements like installing a wheelchair ramp can wipe out what little financial cushion we have left

In recent years, the introduction of the brain-gut axis (BGA) theory has provided a new perspective for the systematic understanding of GERDs pathogenesis